ReviewMolecular medicine reports2026
Interaction of circular RNAs with splicing factors in cervical cancer: Modulation, interplay and theranostics (Review).
Review in Molecular medicine reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cervical cancer (CCa) is a worldwide health concern, particularly in low‑ and middle‑income countries. Human papillomavirus infection is a key risk factor in the development of CCa. Noncoding RNAs (ncRNAs), including microRNAs (miRNAs), circular RNAs (circRNAs) and long ncRNAs (lncRNAs), are important regulators of cancer progression, including CCa, offering potential therapeutic targets. Compared with lncRNAs and miRNAs, circRNAs are the least studied ncRNAs. circRNAs, distinguished by a closed‑loop structure and resistance to exonucleases, serve diverse roles in cancer, functioning as miRNA sponges and regulating gene expression. circRNAs are produced primarily by back‑splicing and comprise both intronic and exonic sequences. Notably, circRNAs are key regulators of alternative splicing, as they are able to enhance the expression of splicing factors (SFs) by sequestering miRNAs. Despite their importance, the interactions between circRNAs and SFs in CCa remain to be elucidated. The present review highlights the interplay between circRNAs and SFs in CCa pathogenesis; it describes the influence of SFs on circRNA production, the regulatory feedback between circRNAs and SFs, and the potential implications of this interaction in CCa diagnostics and therapeutics. To conduct the present review a targeted literature search was conducted across PubMed, Scopus and Google Scholar using defined search terms to identify peer‑reviewed studies published between 2006 and 2024. The findings were synthesized to explore the mechanistic insights and translational implications of circRNA‑SF interactions in CCa.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.